M

Mentice AB
STO:MNTC

Watchlist Manager
Mentice AB
STO:MNTC
Watchlist
Price: 24.6 SEK -1.6%
Market Cap: 629m SEK
Have any thoughts about
Mentice AB?
Write Note

Mentice AB
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mentice AB
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
Mentice AB
STO:MNTC
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
RaySearch Laboratories AB (publ)
STO:RAY B
Other Equity
-kr2.4m
CAGR 3-Years
37%
CAGR 5-Years
20%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Other Equity
kr95.5m
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
7%
O
Ortivus AB
STO:ORTI B
Other Equity
kr813k
CAGR 3-Years
164%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Other Equity
kr1.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Other Equity
kr42.5m
CAGR 3-Years
31%
CAGR 5-Years
21%
CAGR 10-Years
N/A
No Stocks Found

Mentice AB
Glance View

Market Cap
629m SEK
Industry
Health Care

Mentice AB provides software and hardware simulation solutions for endovascular therapies. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2019-06-18. The company provides software and hardware simulation solutions and related services for endovascular therapies. The Company’s solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Company’s solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The firm also covers neurovascular, cardiovascular and peripheral interventions, among others. The company is active globally.

MNTC Intrinsic Value
52.82 SEK
Undervaluation 53%
Intrinsic Value
Price
M

See Also

Back to Top